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Abstract
The Chandipura virus (CHPV) belonging to the Vesiculovirus genus and Rhabdoviridae family, has recently been associated
with a number of encephalitis epidemics, with high mortality in children, in different parts of India. No full length genome
sequences of CHPV isolates were available in GenBank and little is known about the molecular markers for pathogenesis. In
the present study, we provide the complete genomic sequences of four isolates from epidemics during 2003–2007. These
sequences along with the deduced sequence of the prototype isolate of 1965 were analysed using phylogeny, motif search,
homology modeling and epitope prediction methods. Comparison with other rhaboviruses was also done for functional
extrapolations. All CHPV isolates clustered with the Isfahan virus and maintained several functional motifs of other
rhabdoviruses. A notable difference with the prototype vesiculovirus, Vesicular Stomatitis Virus was in the L-domain flanking
sequences of the M protein that are known to be crucial for interaction with host proteins. With respect to the prototype
isolate, significant additional mutations were acquired in the 2003–2007 isolates. Several mutations in G mapped onto
probable antigenic sites. A mutation in N mapped onto regions crucial for N-N interaction and a putative T-cell epitope. A
mutation in the Casein kinase II phosphorylation site in P may attribute to increased rates of phosphorylation. Gene junction
comparison revealed changes in the M-G junction of all the epidemic isolates that may have implications on read-through
and gene transcription levels. The study can form the basis for further experimental verification and provide additional
insights into the virulence determinants of the CHPV.
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Introduction
Chandipura Virus (CHPV), a member of the family Rhabdo-
viridae and genus Vesiculovirus was first isolated in 1965 from two
febrile cases during an outbreak of Dengue and Chikungunya in
Nagpur, Maharashtra state, India [1,2]. In recent years, it has
been associated with a number of encephalitis epidemics in
different states of India; Andhra Pradesh (AP) in 2003 [3] and
2007, Gujarat in 2004 [4], and Maharashtra in 2007 [5] and 2009.
Further, the virus was also shown to be responsible for sporadic
encephalitis in children from AP [6]. Although, the virus closely
resembles the prototype Vesiculovirus, Vesicular Stomatitis Virus
(VSV), it could be readily distinguished by its ability to infect
humans [7]. The CHPV has also been isolated in Nigeria from
hedgehogs [8] and in Sri Lanka from macaques [9]. Sandflies are
considered as the vectors for this pathogen [10,11] while
antibodies against the virus have been detected in a wide range
of vertebrate animals [12]. Cells of insect origin and vertebrate
animals were found to be susceptible to virus replication [13].
The viral genome of CHPV consists of a linear, single stranded
negative sense RNA molecule of approximately 11,120 base pairs.
A 49 nucleotide leader RNA is transcribed from the 39 genomic
terminus, which is non-translated, uncapped, and non-polyade-
nylated. Transcription of viral genes occurs in a sequential manner
from a single promoter at the 39 end of the genome resulting in a
decreasing amount of each transcript in the order 39-N-P-M-G-L-
59 similar to VSV [7,14]. The five genes encode the respective
proteins of different functionalities. The nucleocapsid (N) binds
with nascent leader RNA and initiates encapsidation of the
replication product concurrent to synthesis [15,16]. The phos-
phoprotein (P) plays an important role in the transcription and
replication of CHPV [17–19]. The matrix protein (M) represents
an important component in the virus structure, assembly and
budding and was shown to have the ability to inhibit gene
expression [20]. The spike glycoprotein (G) is responsible for virus
entry into cells and induction of neutralizing antibodies. The
precise mechanism of CHPV fusion has not been elucidated so far.
However, for VSV, it has been proposed that low pH induced
conformational change in the G protein within the endosome
subsequent to viral entry enables membrane fusion to release the
core particle in two sequential steps into the host cytoplasm [21].
The large protein (L) is a subunit of the RNA polymerase complex.
It retains the enzymatic activities of polymerase, capping, and
polyadenylation. A 46 nucleotide trailer sequence at the 59 end
remains untranscribed [7].
The CHPV encephalitis epidemics have been consistently
reported to be associated with a very high case fatality rate
(CFR) ranging from 55–78% [3,4]. The virus has thus emerged as
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the epidemics of encephalitis in children [3] the G, N and P genes
of the AP virus isolates from the 2003 outbreak were compared
with the 1965 prototype though the associations of the observed
mutations to the pathogenesis remained to be fully determined
[22]. No full-length sequences of CHPV isolates were available in
GenBank. Further, compared to other rhabodoviruses, an in-depth
genomics- and proteomics-based characterization of CHPV has
not been reported.
The present study provides the complete genomic sequences of
four isolates representing the major recent epidemics in AP, 2003
and 2007; Gujarat, 2004; and Maharashtra, 2007. We also de-
duced the full genome sequence of the 1965 prototype isolate from
the available GenBank sequences [22,23]. We carried out a
sequence/structure-based characterization of the deduced protein
sequences, genomic termini and the gene junctions of the isolates
from the epidemics vis-a `-vis the prototype isolate. Wherever
appropriate, comparisons were performed with other members of
the Rhabdoviridae family such as VSV, Isfahan virus (ISFV) (genus:
Vesiculovirus), rabies virus (RABV) (genus: Lyssavirus) and Bovine
Ephemeral fever virus (BEFV) (genus: Ephemerovirus) and also more
divergent and newer rhabdoviruses such as the turbot rhabdovirus,
Scopthalmus maximus rhabdovirus (SMRV). An attempt has also
been made to understand the difference in pathogenicity between
the 1965 virus and the recent CHPV virus isolates.
Methods
Virus and RNA isolation
The clinical materials (throat swabs/serum) were obtained from
infected children (between the ages of 4 and 16 years) from the
CHPV epidemics during the period 2003 – 2007. The viruses were
passaged twice in rhabdomyosarcoma (RD) cell line. The viral RNA
was isolated using QIAamp Viral RNA Mini kit (QIAGEN,
Valencia, CA) according to the manufacturer’s instructions. Four
CHPV isolates from AP (CIN0327, CIN0755), Gujarat (CIN0451)
and Maharashtra (CIN0728) were chosen for full-length genome
sequencing. The GenBank accession numbers of these four whole
genome sequences are GU212856.1 (CIN0327), GU212857.1
(CIN0451), GU212858.1 (CIN0751) and GU190711.1 (CIN0755).
The full genome sequence of the 1965 prototype isolate (CIN6514)
was deduced from the available GenBank sequences having
accession numbers AY614724, AF128868, J04350, AY614717
and AJ810083.
RT-PCR and sequencing
SuperScript
TM II reverse transcriptase was used for the cDNA
synthesis and Platinum Pfx DNA polymerase was used for the
amplification according to the manufacturer’s instructions (Invi-
trogen, CA). Amplified fragments were visualized by ethidium
bromide agarose gel staining, extracted from the gels and
sequenced directly using BigDye Terminator Cycle Sequencing
kit (Applied Biosystems, CA).
For the designing of primers, the deduced nucleotide sequence
of the 1965 isolate was used. The N, P, M and G genes were
amplified in a single stretch and the L gene was amplified in four
overlapping fragments.
The 39 and 59 end of all the isolates were amplified using
primers LeF1 and NF7 and LF13 and TeR1 respectively. The
primers LeF1 and TeR1 were used as described by Nichol &
Holland, 1987. The amplified products were cloned into pGEM T
easy vector (Promega, Madison, USA) and sequenced using T-7
and SP-6 promoter primers. Table S1 provides the list of primers
used. As the isolates have undergone low levels of passage, the
possibility of mutations being incorporated during cell culture
adaptation, can be ruled out. The Genbank accession numbers of
the isolates are: GU212858.1 (CIN0327), GU212856.1 (CIN0451),
GU190711.1 (CIN0728) and GU212857.1 (CIN0751).
Multiple sequence alignments and Phylogenetic trees
Whole genome sequences were aligned using ClustalW as
implemented in MEGA. v.5.05 [24]. Phylogenetic analyses of the
whole genomes of CHPV along with other rhabdoviruses were
carried out in MEGA, employing the Maximum Likelihood (ML)
method with the Tamura Nei nucleotide substitution model and a
gamma distribution of rate heterogeneity among sites (C). For
individual genes N, P, M, G and L, phylogenetic trees were
obtained from deduced amino acid sequences using the ML
method with the WAG + C amino acid substitution model [25].
The reliability of the different phylogenetic groupings was eva-
luated by considering 1000 bootstrap replications. The percent
nucleotide and amino acid identities between the sequences were
calculated using p-distances. The alignment of the N, P, M, G and
L amino acid sequences of the CHPV isolates and other rhab-
doviruses was done using the Profile Alignment Mode of ClustalX
v.2.0.11 [26]. Profile alignment was done where the alignment of
CHPV and other vesiculoviruses along with BEFV and SMRV
was used as profile 1 and the lyssavirus alignment was taken as
profile 2. Though all viruses as in the phylogenetic tree (Fig. 1)
were used for the alignments, only representative viruses are
included in all the alignment figures.
Functional motif search and tertiary structure modeling
The amino acid sequences of the N, P, M, G and L proteins
were scanned for biologically important motifs using the
Scanprosite tool of ExPaSy (http://expasy.org/tools/). Homology
modeling of the N, M and G proteins was done with Modeler [27]
in the Discovery Studio (DS) interface (Accelyrs Inc, USA). Models
were energy minimized in DS employing the steepest descent
followed by the conjugate gradient algorithms. The stereochemical
quality of the energy minimized models was evaluated in
PROCHECK [28]. The quality of the models was also evaluated
using PROSA [29] (https://prosa.services.came.sbg.ac.at/prosa.
php) and also using the neural network algorithm implemented in
the PROQ server [30] (http://www.sbc.su.se/ ˜bjornw/ProQ/
ProQ.cgi). In PROSA, the quality scores of a protein are displayed
in the context of all known protein structures while the PROQ
predictor is based on a number of structural features and the
protein quality is quantified by the location in the plane formed by
the two indexes LGscore (i.e., the -log of a p-value) and MaxSub
(ranging 0 – 1). Depending on the specific values of these indexes,
the model can be qualified as: correct if LGscore.1.5 and
MaxSub.0.1, as good if LGscore.3 and MaxSub.0.5, and as
very good if LGscore.5 and MaxSub.0.8).
The crystal structure of VSV nucleoprotein in complex with
RNA (PDB ID: 2GIC), which had 50.5% sequence identity and
71.6% sequence similarity with the N query sequence (GenBank
Accession No: AY614724), served as the template for the CHPV
‘N’ protein model. The Ramachandran plot of the model
(residues: 2 to 422) showed 98.7% residues in the allowed region,
0.8% in the generously allowed and 0.5% residues in the
disallowed region. Further, validation of the minimized N protein
model with ProSA indicated that the overall model quality was
excellent (Z score of 28.05 in comparison with 28.34 of the
template). The model was evaluated as ‘‘correct’’ according to the
LG score (4.542) and MaxSub index (0.157).
The crystal structure of VSV ‘M’ protein (PDB ID: 1LG7)
which shared 40.4% sequence similarity and 20.9% sequence
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AF128868) was taken as the template to build the CHPV M
protein homology model. The model (res: 61 to 229) had 98.7%,
0.7% and 0.7% residues in the allowed regions, additionally
allowed regions and disallowed regions of the Ramachandran plot
respectively. Validation of the predicted model with ProSA
indicated that the overall quality of the minimized M protein
model was very good (Z score of 26.36 in comparison with 25.24
of the template). The model was also evaluated as ‘‘correct’’
according to the LG score (4.51) and MaxSub index (0.27).
The G protein was modeled using 2J6J.PDB, the crystal
structure of the prefusion form of VSV as the template, which
shared 49.2% sequence similarity and 31.6% sequence identity
with the G query sequence (GenBank Accession No: AY614717).
The disulphide bridges for the model were specified according to
the cystein linkages deduced by Walker and Kongsuwan for the
structural model of rhabdovirus glycoproteins [31]. The Rama-
chandran plot of the model (residues: 22 to 526) showed 97.9% of
the residues to be in allowed region, 1.2% of the residues in the
generously allowed region and only 0.1% in the disallowed
region. Further, ProSA indicated that the overall quality of the
minimized G protein model was good (Z score of 24.32 in
comparison with 27.47 of the template). The model was
evaluated as ‘‘correct’’ according to the LG score (4.24) and
MaxSub index (0.075). Solvent accessibility analysis of the G
model was obtained by DSSP [32]. The model was submitted to
the Conformational Epitope Prediction server [33] for the
prediction of Antigenic Determinants (AD) and Conformational
Epitopes (CE).
Results
The whole genome lengths of the CHPV isolates, CIN0327 (AP,
2003), CIN0451 (Gujarat, 2004), CIN0755 (AP, 2007) and
CIN0728 (Maharashtra, 2007) were 11,124, 11,124, 11,087 and
11,098 nucleotides respectively. The phylogeny of the whole
genomes of the CHPV isolates and other rhabdoviruses (Fig. 1)
showed CHPV to be closest to ISFV with 100% bootstrap support
and mean nucleotide identity of 62%, followed by the other
vesiculoviruses, (identity ranging from 51.2–55.4%), the SMRV
(46.8%), BEFV (43.7%) and finally the lyssaviruses (41 – 42%). All
the CHPV isolates including the prototype CIN6514 formed a
monophyletic cluster with a 100% bootstrap value. CIN0327 and
CIN0451 clustered together with ,100% bootstrap support and
so also CIN0728 and CIN0755. CIN0327 was found to be closest
to the prototype strain CIN6514 with 96.46 percent nucleotide
identity (PNI) followed by CIN0451 (96.36), CIN0728 (96.31) and
CIN0755 (96.29).
Phylogenetic analyses of the proteins coded by the individual
genes (Fig. S1) indicated similar topology as in the whole genomes.
Except for the P protein, the clustering of the selected
vesiculoviruses was supported by greater than 60% bootstrap
support. The mean divergence among the rhabdoviruses selected
varied from 48.7% for the L protein to 74.8% for the P protein,
while the divergence among the vesiculoviruses varied from 29.7%
to 57.3% for the L protein and P protein respectively. Fig. S2
further represents the comparison of the pairwise PNI and percent
amino acid identity (PAI) among the CHPV isolates for the N, P,
M, G and L genes/proteins.
Figure 1. Phylogenetic tree of the whole genomes of the CHPV isolates and other rhabdoviruses using the Maximum likelihood
method as implemented in MEGA. v.5.05. Bootstrap values greater than 60% are indicated at the appropriate nodes. Scale bar indicates number
of nucleotide substitutions per site. Abbreviations: CHPV (Chandipura virus; acc nos. GU212856.1-58.1 [CIN0327, CIN0451, CIN0751], GU190711.1
[CIN0728], CIN6514 [deduced 1965 CHPV sequence]); ISFV (Isfahan virus; acc. no. AJ810084.2); VSV (vesicular stomatitis virus; acc. no. NC_001560.1);
PFRV (pike fry rhabdovirus; acc. no. FJ872827.1); SVCV (spring viraemia of carp virus; acc. no. DQ097384.2); SMRV (Scopthalmus maximus rhabdovirus;
acc. no. HQ003891.1); BEFV (Bovine Ephemeral fever virus; acc. no. AF234533.1); MOKV (Mokola virus; acc. no. NC_006429.1); EBLV-1 (European bat
lyssavirus-1; acc. no. EU293112.1); IRKV (Irkut virus; acc. no. EF614260.1); ABLV (Australian bat lyssavirus; acc. no. AF418014.1); RABV (rabies virus; acc.
no. GQ918139); ARAV (Aravan virus; acc. no. EF614259.1); EBLV-2 (European bat lyssavirus-2; acc. no. NC_009528.1); KHUV (Khujand virus; acc.
no. EF614261.1).
doi:10.1371/journal.pone.0030315.g001
Comparative Genomic Analysis of Chandipura Virus
PLoS ONE | www.plosone.org 3 January 2012 | Volume 7 | Issue 1 | e30315The CHPV isolates of 2003–2007 exhibited several amino acid
substitutions when compared with the prototype strain, CIN6514
(Table 1). In addition to the four whole genome isolates, the
available partial G, N and P genes [22] of seven other isolates from
the AP, 2003 outbreak (CIN0309R, CIN0318R, CIN0327R,
CIN0327M, CIN0331M, CIN0360R, CIN0360V (GenBank
accession nos. AY614718-AY614723 and AY614725-AY614731)
were also included in the comparison. The importance and
possible role of the mutations observed with respect to the
prototype strain as well as with other rhabdoviruses are described
here.
Nucleocapsid protein
A putative casein-type phosphorylation site [ST]X(2)[DE] at
Ser389 [34] that is conserved in all lyssaviruses (as SXXE) and also
shown to be crucial for viral RNA transcription and replication
[35] was noted in CHPV (as SRDD) at equivalent position 362 but
not in other vesiculoviruses (Fig. 2).
CHPV N shared 50.5% identity with the N protein of VSV, its
closest neighbour, the crystal structure of which was determined
recently [36]. A single chain of the N-RNA crystal structure of
VSV (PDB ID: 2GIC) was taken as the template to model the
nucleoprotein of CHPV (Fig. 3A) to gain insights into the N-N
interactions which stabilize the nucleocapsid assembly [15]. The
CHPV ‘N’ model comprised of 21 helices and 8 strands and
showed an overall RMSD of 0.05A ˚ with respect to the template.
The Ser340-Val375 loop in the VSV structure, which extends to
interact with the adjacent molecule in the N protein ring, was
maintained as a loop in the model (Arg340-Val375) (Fig. 2) with a
RMSD of 0.95 A ˚ with respect to the template. This thirty five-
residue stretch was conserved in all the CHPV isolates.
Residue Arg143 from the VSV N terminal lobe, involved in
binding to the phosphates group of RNA was conserved in the
CHPV isolates as also in all the rhabdoviruses included in this
study (Fig. 2). Arg146 also involved in RNA binding was conserved
in all vesiculoviruses and BEFV, with a homologous substitution
Lys146 noted in the lyssaviruses. Another interacting residue from
the same lobe Lys155 in VSV was changed to ‘Thr’, a non
conservative change in all the CHPV isolates. RNA binding
residues from the C-terminal lobe of VSV nucleoprotein, Lys286
and Arg408 were strictly maintained in all the rhabdoviruses
studied whereas another interacting residue Arg317 was replaced
by Leu317 in all the CHPV isolates in the same lobe. Two
additional residues, Arg214 and Arg312 placed in the RNA
binding cavity but not making contact with the RNA in VSV were
conserved in all the rhabdoviruses. Asp199 which is bonded to
Arg214 by a salt bridge was also conserved. Tyr215, which stacks
against nucleotide 1 of RNA, was conservatively substituted by
Phe215 in all the CHPV isolates. Tyr324 and Tyr415 from the C-
terminal lobes that interact with the hydrophobic portion of the
side chain of the Arg309 were conserved in CHPV and ISFV
though the Arg309 of VSV was substituted by Lys309, a
homologous residue in CHPV. The Glu419 which neutralizes
the positive charge of Arg309 in VSV was replaced by a ‘Lys’ in
CHPV at the same position. Except Met166, residues Lys207,
Asn187 and Asp188 responsible for maintaining the hydrophobic
interaction between the N-terminal lobes were maintained in
CHPV and most vesiculoviruses. Val184 also involved in the same
interaction was substituted by a similar residue Ala184 in CHPV.
When compared with CIN6514 two amino acid substitutions,
namely, Lys37Arg and Glu364Asp (except in CIN0331M) were
observed in the 2003–2007 isolates (Table 1). The Lys37Arg
mutation appeared within the N-terminal region containing the
first 47 amino acid residues which have been shown to be critical
for self assembly of N [16]. The same mutation was located in a
putative CAMP phosphorylation motif [RK](2)X[ST] at residue
position 37 (with the phosphorylation site at 40Thr) in the CHPV
isolates. The mutation however being in the first position of the
motif, the phosphorylation site was maintained. This phosphor-
ylation site was conserved at the equivalent position in several
rhabdoviruses including BEFV, European bat lyssavirus-1 (EBLV-
1), European bat lyssavirus-2 (EBLV-2), Irkut virus (IRKV),
Australian bat lyssavirus (ABLV) and Aravan virus (ARAV) but
not VSV and ISFV (Fig. 2). The Glu364Asp substitution appeared
within the C-terminal region shown to be important for N-RNA
interaction [16] and also the stretch Arg340-Val375, important for
N-N interactions in VSV. It was further found to map onto the
amino acid stretch 373–395 (region 357–366 in CHPV) of the
lyssaviruses, delineated as an important T-cell epitope in humans
and mice [34]. This stretch was also predicted as a T-cell epitope
in CHPV (data not shown) by predictive methods, SYFPEITHI
[37] and HLA_Bind [38]. Though the mutation also appears in
the putative Casein phosphorylation site Ser362, the phosphory-
lation motif is maintained.
Phosphoprotein
In general three domains and a hypervariable hinge region have
been described in the P protein of VSV [39]. Domain 1 is
responsible for the association of P with L and needs to be
phosphorylated in several sites for optimal transcription activity
[40]. A Casein Kinase II (CK II) phosphorylation motif,
[ST]X(2)[DE], was found in the prototype CHPV isolate where
Ser62 is the phosphorylation site (Fig. 4) which is specifically
modified by CKII [41]. The P protein alignment of the CHPV
isolates with other rhabdoviruses (Fig. S3) indicated that
phosphorylation motifs were found at more or less equivalent
positions in VSV (Ser60, Thr62 and Ser64), ISFV (Ser56) and
SVCV (Ser64). Several residues are conserved between CHPV,
VSV and also ISFV in domains II and III (Fig. 4). On the other
hand, the region in CHPV corresponding to the VSV hinge region
appears to be least conserved. The short lysine-rich motif
(FSKKYKF) of lyssaviruses critical for ribonucleoprotein (RNP)
binding [42] was not noted in CHPV and the other rhabdoviruses
included in this study (Fig. S3). The dynein light chain 8 (LC8)
binding motif [KR]XTQT of the lyssaviruses [43,44] that had
earlier been suggested as a molecular factor that links viral RNP to
the host cell transport system in RABV [45] was also not found to
be maintained in the vesiculoviruses and other rhabdoviruses
studied here. More recent studies [46] have however proposed
that LC8 does not play a role in the retrograde axonal transport of
RABV, but may have a role in promoting efficient viral
transcription.
An overlapping ORF (nucleotide position 1445–1687/length
243 nt) in the +2 reading frame was predicted within the P gene
(nucleotide position 1363 – 2244/length 882 nt) of CHPV using
the tool ‘ORF Finder’ at NCBI (http://www.ncbi.nlm.nih.gov/
projects/gorf/).
Among eight mutations observed in the 2003–2007 isolates, a
Glu64Asp mutation was observed in all the isolates (Table 1). It was
found to bepresent inthe thirdposition oftheCKIIphosphorylation
site. The sequence motif in these isolates was SEDD while that in
CIN6514 was SEED and thus the phosphorylation motif is
maintained. The significance of the mutations Gly112Glu, Ala214-
Val and Ile270Val, in several isolates could not be ascertained.
Matrix protein
The N terminus of the matrix protein of all the CHPV isolates
contained a highly conserved PPSY sequence (position: 30) as was
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Protein
Polypeptide
position
CIN
6514
CIN
0318R
CIN
0309R
CIN
0360V
CIN
0360R
CIN
0331M
CIN
0327M
CIN
0327M
CIN
0327
CIN
0451
CIN
0728 CIN 0755
G 1 6 I ..V V .... . . .
1 7 T ........ A . .
1 9 L SSSSSSSS S S S
2 2 Y SSSSSSSS S S S
3 0 N ..S S .... . . .
4 0 R KKKKK. . K K K K
213 D . V . . . . . . . . .
2 1 8 I ..V V .... . . .
2 1 9 T AAAAAAAA A A A
2 2 2 G AAAAAAAA A A A
2 6 4 R KKKKKKKK K K K
2 6 9 H PPPPPPPP P P P
3 6 7 P MM. . MMMM M M M
4 2 4 L .....V V V . . .
5 0 2 R ..K K .... . . .
5 0 3 K ........ . R .
N 3 7 K RRRRRRRR R R R
1 4 0 F ........ L . .
163 A . T . . . . . . . . .
3 6 4 E DDDD DDD D D D
4 1 3 V ..II.... . . .
P 6 4 E DDDDDDDD D D D
103 Q . R . . . . . . . . .
1 1 2 G . E. . EEEE . E E
1 8 0 I ..V V .... . . .
2 1 4 A VVV. VV. . V V V
2 2 1 M ........ I . .
2 5 8 N .....T .. . . .
270 I V V . . V . . . V V V
M 97 D ---- ---- ---- ---- ---- ---- ---- . . N .
L 52 D ---- ---- ---- ---- ---- ---- ---- . N . .
108 D ---- ---- ---- ---- ---- ---- ---- V . . .
115 E ---- ---- ---- ---- ---- ---- ---- . . D .
136 I ---- ---- ---- ---- ---- ---- ---- . . V V
139 V ---- ---- ---- ---- ---- ---- ---- I . . .
209 V ---- ---- ---- ---- ---- ---- ---- . . I .
298 I ---- ---- ---- ---- ---- ---- ---- . V . .
317 A ---- ---- ---- ---- ---- ---- ---- . . . T
320 P ---- ---- ---- ---- ---- ---- ---- . . . Q
408 T ---- ---- ---- ---- ---- ---- ---- . . A A
409 N ---- ---- ---- ---- ---- ---- ---- S S . .
586 E ---- ---- ---- ---- ---- ---- ---- D D . .
649 K ---- ---- ---- ---- ---- ---- ---- R . . .
652 I ---- ---- ---- ---- ---- ---- ---- . . . L
924 K ---- ---- ---- ---- ---- ---- ---- . . R R
1070 G ---- ---- ---- ---- ---- ---- ---- S S . .
1288 T ---- ---- ---- ---- ---- ---- ---- A . . .
1324 N ---- ---- ---- ---- ---- ---- ---- . . S S
1550 S ---- ---- ---- ---- ---- ---- ---- N . . .
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and PPxY motif of other rhabdoviruses except Khujand virus
(KHUV) (Fig. 5), implicated to be involved in the late stage in virus
budding [47]. Another core motif P[ST]AP reported to bind
components of vascular protein sorting pathway, such as tumor
susceptibility gene 101 (Tsg 101) [48], was observed to be strictly
conserved PTAP in all the CHPV isolates at position 42 as also in
other vesiculoviruses (PSAP) except pike fry rhabdovirus (PFRV)
and spring viraemia of carp virus (SVCV). The motif was seen to
be Px[TS]AP in some of the lyssaviruses at position 21. The
composition of amino acids surrounding the late budding domain
(L-domain) core motifs, which are critical for efficient L-domain
activity and for interactions with host proteins in the context of
VSV infection [49] though found to be conserved in all the CHPV
Figure 2. Profile alignment of N protein of representative CHPV isolates (shown in bold) with other representative rhabdoviruses.
Residues known to be critical for VSV N protein function are highlighted in grey to indicate conservation. Putative CK II phosphorylation sites are
underlined while putative CAMP phosphorylation sites are italicized and underlined. The two-headed arrow delineates the T cell epitope of
lyssaviruses. Mutations in CHPV isolates are indicated by downward arrows.
doi:10.1371/journal.pone.0030315.g002
Protein
Polypeptide
position
CIN
6514
CIN
0318R
CIN
0309R
CIN
0360V
CIN
0360R
CIN
0331M
CIN
0327M
CIN
0327M
CIN
0327
CIN
0451
CIN
0728 CIN 0755
1731 W ---- ---- ---- ---- ---- ---- ---- . . R .
1769 H ---- ---- ---- ---- ---- ---- ---- N N N N
1832 K ---- ---- ---- ---- ---- ---- ---- R . . .
1852 L ---- ---- ---- ---- ---- ---- ---- F F F F
1940 S ---- ---- ---- ---- ---- ---- ---- . . L .
1992 H ---- ---- ---- ---- ---- ---- ---- R R . R
2045 G ---- ---- ---- ---- ---- ---- ---- . . . R
2050 N ---- ---- ---- ---- ---- ---- ---- S S S S
A ‘dot’ indicates a match with the amino acid in CIN6514 and a dash indicates non-availability of sequence data. Whole genome isolates of this study are underlined.
doi:10.1371/journal.pone.0030315.t001
Table 1. Cont.
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more similar to that of ISFV.
At the amino acid level, M protein was found to be totally
conserved in all the isolates but CIN0728 (Fig. 5). This isolate
possessed an Asp97Asn substitution ,w h i c hr e s u l t e di nt h eg a i no fa
putative N-glycosylation site. A homology based model of the M
protein (Fig. 3B) based on the crystal structure of the VSV M protein
[50] showed that the Asp97Asn mutation was located in a loop region.
Figure 3. Homology models of CHPV proteins and mapping of significant functional residues. All observed CHPV mutations (residue
numbering as per the location in the sequence) in cyan. (A) Nucleoprotein: RNA binding residues shown in orange, residues part of RNA binding
groove in blue and loop Ser340-Val375 in yellow. (B) Matrix (C) Glycoprotein: BEFV antigenic site G3 shown in shades of grey.
doi:10.1371/journal.pone.0030315.g003
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The GFPP motif involved in fusion [51] was conserved in all the
CHPV isolates at position 129 as in all the other vesiculoviruses
(Fig. 6). The residue corresponding to Arg333 in RABV, within
the rabies antigenic site III and reported to be involved in
neuropathogenicity [52] was found to be a conserved Arg356 in all
the CHPV isolates as in all vesiculoviruses and many of the
lyssaviruses considered in this study.
The G protein of all CHPV isolates possessed two putative
glycosylation sites at positions 175 and 335. Of these, the first site
that appears to be associated with antigenic site G2 of BEFV [53]
was found to be present in all other vesiculoviruses while the
second one was present in all rhabdoviruses except SMRV and
BEFV.
Among all the major viral proteins, the G protein was the least
conserved with PAI varying from 98.47–99.81 (Fig. S2). With
respect to the prototype isolate, eleven amino acid mutations,
Thr17Ala (only in CIN0451), Leu19Ser, Tyr22Ser, Lys40Arg (in
CIN0327), Thr219Ala, Gly222Ala, Arg264Lys, His269Pro,
Pro367Met, Leu424Val, Lys503Arg (only in CIN0728) were
noted in the 2003–2007 whole genome isolates (Table 1) and six of
these substitutions (Leu19Ser, Tyr22Ser, Thr219Ala, Gly222Ala,
Arg264Lys, His269Pro) were recorded in the other 2003 partially
sequenced isolates also. Of these six mutations Thr219Ala,
Gly222Ala, Arg264Lys, and His269Pro could be mapped (Fig. 6)
onto antigenic site G3 of BEFV [53,54], and equivalent site G of
RABV [55]. The mutations, Leu19Ser and Tyr22Ser were not
part of any antigenic site. A substitution Pro367Met could be
mapped within the RABV antigenic site III [52,55,56]. A
substitution Ile218Val also in antigenic site G3 was observed in
two of the 2003 partially sequenced isolates.
A homology model of the ‘G’ ectodomain (Fig. 3C) was built to
study the spatial distribution of the antigenic stretches bearing the
critical mutations, on the three dimensional structure of the
protein. The three discontinuous amino acid stretches (res: 53–63,
215–229, 260–273) of antigenic site G3 were observed to be
spatially close in the G protein model. Critical mutations
Thr219Ala, Gly222Ala, Arg264Lys, and His269Pro were found
to be surface exposed. Three of these amino acid residue stretches
also featured in the predicted antigenic determinants (AD Nos. 9
and 11 in Table S2A) comprising two conformational epitopes
[213–222, 263–267] (CE No 8) and [263–267, 270–284] (CE No
10) in Table S2B.
Large protein
Invariant residues in the L protein are embedded into blocks of
conserved stretches separated by variable regions [57–59]. Six
such blocks have been defined for Rhabdoviruses and paramyxo-
viruses [60,61]. The alignment of the CHPV with other
rhabdoviruses was done (Fig. S4) to note the degree of
conservation of these blocks in the CHPV isolates. The equivalent
Block I in CHPV contained hydrophobic residues particularly in
Figure 4. Alignment of P protein of representative CHPV isolates (indicated in bold) with closely related vesiculoviruses VSV and
ISFV. All putative phosphorylation sites are underlined. The different domains defined for the P protein of VSV are indicated by two-headed dashed
overhead arrows. The mutations within the CHPV isolates are indicated by downward arrows.
doi:10.1371/journal.pone.0030315.g004
Figure 5. Profile alignment of M protein (res: 1 – 117) of representative CHPV isolates (indicated in bold) with other representative
rhabdoviruses. The conserved PPxY and Px[TS]AP motifs are highlighted in grey. Putative glycosylation sites are underlined. The mutations within
the CHPV isolates are indicated by downward arrows.
doi:10.1371/journal.pone.0030315.g005
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289). The third conservative stretch (res: 340–354) in the block I of
CHPV showed an invariant GHP motif (res: 349–351) as in all the
rhabdoviruses studied here. Blocks II and III consist of the major
functional domains. The pre-A motif which has been shown to be
involved in the positioning and binding of the RNA template [62]
as well as the KERE motif [61] were found to be well conserved
among all the rhabdoviruses included in this study. The four
conserved regions in negative-stranded RNA virus L proteins (A–
D) in block III [61] were conserved in the CHPV isolates and also
well conserved among the other rhabdoviruses. The GG[IL]EG
(668–672) motif and the invariant pentapeptide QGDNQ (702–
706) with precise spacing between them, in the block III as noted
earlier in measles virus [63] were strictly conserved in all the
Figure 6. Alignment of G protein of representative CHPV whole genome isolates (in bold) with other representative rhabdoviruses.
BEFV antigenic sites and RABV antigenic sites are indicated by arrows above the sequence. Functionally important motifs are highlighted in grey and
putative glycosylation sites are underlined. The signal peptide is indicated by dashed arrow. Highly conserved cysteine residues are highlighted in
faint grey. Mutations within CHPV isolates are indicated by downward arrows.
doi:10.1371/journal.pone.0030315.g006
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numerous cysteine and histidine invariant residues. Block VI
showed the GXGXG motif as GDGSG sequence in the CHPV
isolates (res: 1659–1663) as also noted in other rhabdoviruses,
preceded by a lysine 19 residues upstream, which could play the
role of polyadenylation or protein kinase activity [60].
The HR motif [64] at position 1217 which has been shown to be
necessary for the PRNT ase activity of the L protein, at the step of
enzyme-pRNA intermediate formation [61], was found to be
conserved in all the CHPV isolates as in other rhabdoviruses and
the equally important R in the vicinity of the HR motif at position
1211 was also conserved in the isolates. The same was also
conserved in the other rhabdoviruses studied here. An experimental
CTL epitope IRRA noted in protozoa [65] was conserved in all the
CHPV isolates at position 1166 and was also conservatively
maintained in other vesiculoviruses (IKRA) and rhabdoviruses
(VKRA).
The L protein of the 2003–2007 isolates, exhibited the maximum
number of mutations with respect to the prototype isolate (Table 1).
A ThrRAla mutation was observed in CIN0327 at position 1288,
immediately adjacent to amino acid residues that correspond to a
strictly conserved stretch (res: 1284–1287) [60]. A Ser1550Asn
mutation was observed only in CIN0327. The Thr1288Ala
substitution can lead to the loss of a potential protein kinase C
phosphorylation site while a Ser1940Leu substitution in CIN0728
can result in a loss of a putative CAMP phosphorylation site at
position 1937. Considering the potential problem of overpredicition
of phosphorylation sites, we looked into the prediction in other
vesiculoviruses as well. None of the related viruses had any
phosphorylation site predicted at equivalent positions and hence
the significance of the same in CHPV may be limited.
Genomic termini
The leader sequence nucleotides were highly conserved among
all the CHPV isolates. With respect to the prototype isolate, two
nucleotide changes, ART at position 19 was observed in all the
isolates and ARC was observed at position 37 in CIN0451. The
trailer terminus showed two nucleotide substitutions, TRCi n
CIN0327 and ART in CIN0755 at positions 1 and 10
respectively, from the trailer start (Fig. S5).
Non-coding regions and gene junctions
The non-coding N-P, P-M and M-G gene junctions contained
the conserved sequence, 39AUAC (U)7 NNUUGUC 59 in all the
CHPV isolates. The gene start sequence which immediately
follows the intergenic dinucleotide (NN) was conserved in all the
isolates for every gene junction (Table 2).
With respect to the prototype isolate, a substitution GRA was
observed at the first position of the M–G junction intergenic
dinucleotide of all the 2003–2007 isolates and ARG substitution
in the P-M junction dinucleotide was noted in CIN0728 and
CIN0755 in the second position. A block of 18 nucleotide insertion
in the G–L junction of CHPV, between the non-transcribed
dinucleotide (CU) and the consensus start sequence, as reported
earlier [66,67] showed changes at only two nucleotide positions in
CIN0451, CIN0728 and CIN0755.
Discussion
The phylogenetic analyses of the whole genomes and the
proteins coded by the individual genes indicated that the CHPV
isolates clustered with the ISFV. The percent nucleotide identities
amongst the five CHPV isolates of the study revealed that the virus
was relatively stable over the period of 42 years (1965–2007). The
percent nucleotide divergence of the CHPV whole genomes varied
from 3.54–3.71, with respect to the prototype. The clustering
pattern among the CHPV isolates observed in the phylogenetic
tree brought out a role of temporal factors rather than geographic
factors in the evolution of CHPV. This pattern was reflected in the
amino acid substitutions as well (Table 1) with CIN0327 and
CIN0451 sharing common mutations just like CIN0755 and
CIN0728, many of them in the L protein. Several functional
motifs characteristic of CHPV were conserved within all the
isolates. In addition, the isolates also maintained functional motifs
observed in other rhabdoviruses.
Comparison of rhabdovirus and paramyxovirus N proteins had
revealed a region with significant identity at the center of the
polypeptide [67] implicated for N-N association [15]. Crystallo-
graphic data on VSV-N showed that this central region forms
constituents of both N- and C- terminal lobe, which come together
to form a cavity that accommodates the RNA [36]. The residues
in this central region of the N protein in the CHPV isolates were
highly conserved as has also been observed in several other
members of the Rhabdoviridae family. The overall architecture of
the binding cavity in the N protein was thus maintained in CHPV.
The Lys37Arg mutation in the N protein of the 2003–2007
isolates, was within the first 47 amino acids that was determined to
have an important role in the oligomerization of N protein in
CHPV [16]. The implication of this homologous substitution
might not be significant in terms of monomeric N-N interaction.
Also, though the mutation occurred within a phosphorylation
motif, the putative phosphorylation site 40Thr was conserved.
Further, the homologous substitution Glu364Asp in the CHPV
isolates was located within the C-terminal region (320–422 aa) and
might not affect RNA recognition [16]. However, as it mapped on
to a probable T-cell epitope, it needs to be experimentally verified
for pathogenicity. The mutation also corresponds to the last 60
amino acids of the C-terminal end of VSV N protein where
sequences known for interaction with the phosphoprotein and
encapsidation are believed to be located [68]. Further it mapped
on to a putative CKII phosphorylation site that was noted only in
CHPV among the vesiculoviruses studied here and the lyssa-
viruses. Therefore, the implication of GluRAsp mutation requires
careful examination. Interestingly, this mutation also positioned
within the thirty five residue loop in the N model corresponding to
the VSV loop responsible for the interaction with the adjacent N
protein ring. Overall the site may be a feature distinguishing
CHPV and VSV.
Among all proteins, the P protein was found to be the least
conserved for the selected rhabdoviruses as well as for the selected
vesiculoviruses. This can explain the lower bootstrap supports
observed for the vesiculovirus cluster, in case of the P protein
phylogeny. Further, though the length of the P protein of CHPV
and VSV differed significantly, yet domains I, II and III aligned
fairly well with gaps noted mainly in the hinge region. Conserved
Table 2. Intergenic dinucleotide for all the gene junctions (39
R 59 direction) in CHPV whole genome isolates.
Gene Junction CIN6514 CIN0327 CIN0451 CIN0728 CIN0755
N–P GA GA GA GA GA
P–M AA AA AA AG AG
M–G GA AA AA AA AA
G–L GA GA GA GA GA
doi:10.1371/journal.pone.0030315.t002
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in mediating the binding of P protein to N-RNA template while
the hypervariable hinge region of the P protein plays an important
role in viral RNA synthesis and in the assembly of infectious VSV
[39], hence the role of the same in CHPV needs further
investigation. An additional ORF could be predicted within the
P gene of the CHPV isolates as was previously identified or
predicted in the P genes of VSV [69], other vesiculoviruses [23,70]
and SMRV [71]. However, the expression of the same in CHPV
remains to be verified experimentally.
Further, in the P protein, a Glu64Asp substitution was
maintained consistently in the 2003–2007 isolates which was found
to be located in the known CKII phosphorylation site. Additional
acidic residues in the CK II phosphorylation motif at positions +1,
+2, +4, and +5 from the start of the phosphorylation site were
observed to increase the rate of phosphorylation and Asp is
preferred to Glu as the provider of acidic determinants [72].
Therefore the GluRAsp substitution could have an impact on the
rateofphosphorylationandhencealteredbiologyofthePproteinas
CKII mediated phosphorylation is indispensable for CHPV P to act
as a transcriptional activator [73]. Also, this phosphorylation
induces a major structural change in the N terminal domain (res:
49–69) of the P protein [18], which is clearly known to be important
in L protein interaction for vesiculoviruses [40]. Implication of the
Glu64Asp mutation merits further experimentation to understand
its role in pathogenicity of the 2003-07 CHPV isolates.
Significant motifs including those involved in virus budding
were identified in the M protein of all CHPV isolates as in most of
the other rhabdoviruses. However, the differences in the L-domain
flanking sequences specifically with respect to VSV may have
implication for interaction with host proteins. Notably both CHPV
and ISFV [74] infect humans unlike VSV. The only mutation,
AspRAsn at position 97 in the M protein which was observed in
CIN0728 resulted in the gain of a putative glycosylation site. The
significance of this mutation in terms of pathogenesis also requires
to be explored.
The fusion motif in the G protein was conserved in all the CHPV
isolates as also in other vesiculoviruses. The homology model of the
G protein ectodomain ofCHPV was alsobuilttostudytheantigenic
fine structure. The model revealed that the sequence stretches of the
BEFV antigenic site G3 which are also known neutralization
epitopes of VSV [53,75], clustered in the three-dimensional
structure of the protein, pointing to the probable implication of
the site in presenting an antigenic face in CHPV. The same also
matched with one of the predicted conformational epitopes (CE),
implyingthat itislikelytobea majorantigenicsite (Table S3B).The
critical mutations in the 2003–2007 isolates could be mapped onto
this CE and were exposed so as to enable interaction with cellular
receptors and antibodies, suggesting that these residues may be
under immune selection pressure. Interestingly, amongst the critical
mutations, the Leu19Ser, Tyr22Ser and Thr219Ala, His269Pro are
nonconservativechanges.Thelasttwosubstitutionsthatarelocated
in the antigenic sites, involve a change from polar residues to non
polar and hydrophobic residues.These changes mayaffectantibody
binding. However other studies in the author’s laboratory [76] have
shown that antibodies induced by a recombinant G protein based
vaccine could efficiently neutralize the different CHPV viruses with
neutralizing titers ranging from 70 to 120 (pers. comm.) suggesting
that these mutations may not significantly alter immunoreactivity.
The invariant amino acids were not distributed randomly in the
L proteins, but were clustered into the six blocks defined previously
[60], compatible with the concept that the L protein needs to have
concatenated functional domains for performing many enzymatic
functions. [59]. The conservation of the GHP motif in Block I
implies the conservation of architecture of this functional domain
in CHPV. Presence of charged conserved stretches throughout
block III around the pentapeptide QGDNQ again points to an
important functional role for the entire block III. The pentapep-
tide domain is proposed to be the active site for template
recognition and/or phosphodiester bond formation in the L
proteins [60] and has been extensively studied by utilizing
deletions and mutations. Any change made to the motif resulted
in complete loss in polymerase activity in RABV [77] and VSV
[78]. The sole change Ser1550Asn in CIN0327, within a defined
conserved block, requires this mutation to be looked into.
The non-coding genomic termini of vesiculoviruses have been
shown to be maintained with blocks of strong conservation [23].
The first 21 nucleotides of the (+) leader RNA is specifically
recognized by the nucleocapsid protein monomer which is
followed by nucleocapsid assembly. Subsequent N-N association
during elongation phase results in subtle conformational changes
to allow for compromised binding specificity so that the
polymerized N can bind to heterogeneous sequences [79].
Therefore the observed ART substitution in all the 2003–2007
CHPV isolates at position 19 from the leader terminus might not
have significant effect on the binding specificity of N.
The gene junctions of CHPV were very similar to those of ISFV
and VSV, as had been observed earlier [23,80]. The intergenic
conserved sequence 39AUAC U(7)NNUUGUC59 in the CHPV
gene junctions had also been reported by Marriott [23]. The stretch
39AUAC U(7) 59 was strictly conserved in every gene junction
amongalltheCHPVisolatesasitiscriticalforbothtermination and
polyadenylation of mRNA and mutations are rarely observed at
these sites as has been shown by in vitro studies [81].
The U(7) polyadenylation signal was followed by two non
transcribed nucleotides 39-NN-59 (-G/CA-) which act as an
essential element for efficient transcription termination [81], signal
for initiation, capping and methylation of downstream mRNA.
The intergenic dinucleotide of the M-G gene junction in the
2003–2007 isolates differed from the prototype strain, at the first
position. Substitutions at the first position have been found to have
an enhancing impact on the amount of readthrough transcripts as
well as the transcription of the upstream gene in VSV [82]. It
would therefore be interesting to quantify the M–G junction
readthrough as well as gene transcripts in CHPV. The other
change ARG, in the P–M junction intergenic dinucleotide which
was noted in CIN0728 and CIN0755 appeared in the second
position. Though single substitutions at the second position were
found to result in only slightly increased levels of read-through
transcripts [83], they are also found to play a small role [84]. It
would be worth studying whether this trend observed in 2007 will
be maintained over time.
Variations in the G–L intergenic region just following the
dinucleotide (NN) were observed earlier in CHPV [23]. The same
trend had been observed in other viruses as well [81,82,65], and
the insertion sequence was hypothesized to be vestigial [65].
Therefore, the variations within the 18 nucleotide insertion in the
G–L intergenic region amongst the 2003–2007 CHPV isolates
observed in this study, possibly does not play any significant
biological role.
Overall, this study presents the whole genome-based character-
ization of CHPV isolates from different encephalitis epidemics at
different time points during 2003–2007 as well as comparison with
the prototype 1965 isolate and the genomes of related rhabdovi-
ruses. Several functional motifs, indicative of pathogenicity, were
found to be conserved in all the CHPV isolates of this study. The
specific regions and sites of differences with VSV may help in
furthering our understanding of host specificity. Over the last four
Comparative Genomic Analysis of Chandipura Virus
PLoS ONE | www.plosone.org 11 January 2012 | Volume 7 | Issue 1 | e30315decades, the CHPV virus also showed significant mutations in the
G, N, P, M proteins and the gene junctions. Our study can further
form the basis for experimental verification by functional assays to
understand the difference in pathogenicity between the 1965 virus
and the more recent CHPV virus isolates and thus provide
important insights into the virulence determinants of the CHPV.
Supporting Information
Figure S1 Protein-based phylogenetic trees of the genes
of the CHPV whole genome isolates and other rhabdo-
viruses using the Maximum likelihood method as
implemented in MEGA. v.5.05. Bootstrap values greater
than 60% are indicated at the appropriate nodes. Scale bar
indicates number of nucleotide substitutions per site.
(TIF)
Figure S2 Pairwise percent nucleotide identity (PNI)
and percent amino acid identity (PAI) among CHPV
whole genome isolates.
(TIF)
Figure S3 Profile alignment of P protein of representa-
tive CHPV isolates (indicated in bold) with other
representative rhabdoviruses. All putative phosphorylation
sites are underlined. The LC8 motif ([KR]XTQT) and the lysine
rich motif (FSKKYKF) in lyssaviruses are highlighted in grey. The
different domains defined for the P protein of VSV are indicated
by arrows. The mutations within the CHPV isolates are indicated
by downward arrows.
(TIF)
Figure S4 Profile alignment of the L protein of repre-
sentative CHPV isolates (indicated in bold) with other
representative rhabdoviruses. Defined blocks of high
conservation designated by roman numerals are shown in different
colors. The conserved motifs, pre-A, A, B, C and D, are indicated
by 2-headed arrowed lines. The nearly uninterrupted stretches of
strictly or conservatively maintained amino acids (Poch et al.,
1990) are indicated by red colored overhead lines. Functionally
important motifs/residues are highlighted in grey. Mutations
within CHPV isolates are indicated by downward arrows and
associated potential phosphorylation sites are underlined.
(PDF)
Figure S5 Leader and trailer sequences in the CHPV
whole genome isolates.
(TIF)
Table S1 Primers used for the amplification and
sequencing of the CHPV whole genomes.
(PDF)
Table S2 Predicted antigenic determinants (A) and
conformational epitopes (B) in the G protein of CHPV.
(PDF)
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